| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gitlab Inc. | 10%+ Owner | Class B Common Stock | 8,888,776 | $665,680,435 | $74.89 | 18 Oct 2021 | By GV 2017, L.P. |
| Verve Therapeutics, Inc. | 10%+ Owner | Common Stock | 0 | $0 | $4.16 | 25 Jul 2025 | By GV 2017 L.P. |
| Verve Therapeutics, Inc. | 10%+ Owner | Common Stock | 0 | $0 | $4.16 | 25 Jul 2025 | By GV 2019 L.P. |
| Verve Therapeutics, Inc. | 10%+ Owner | Common Stock | 0 | $0 | $4.16 | 25 Jul 2025 | By GV 2023, L.P. |
| Gitlab Inc. | 10%+ Owner | Series C Preferred Stock | 0 | 18 Oct 2021 | By GV 2017, L.P. | ||
| Gitlab Inc. | 10%+ Owner | Series D Preferred Stock | 0 | 18 Oct 2021 | By GV 2017, L.P. |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VERV | Verve Therapeutics, Inc. | 25 Jul 2025 | 3 | $0 | 4 | 10%+ Owner | 28 Jul 2025, 17:19 |
| VERV | Verve Therapeutics, Inc. | 04 Nov 2022 | 7 | -$3,025,611 | 4 | Member of 10% Group | 08 Nov 2022, 16:04 |
| VERV | Verve Therapeutics, Inc. | 02 Nov 2022 | 14 | -$5,310,658 | 4 | Member of 10% Group | 04 Nov 2022, 16:16 |
| VERV | Verve Therapeutics, Inc. | 31 Oct 2022 | 16 | -$6,501,031 | 4 | Member of 10% Group | 02 Nov 2022, 16:25 |
| GTLB | Gitlab Inc. | 18 Oct 2021 | 3 | $0 | 4 | 10%+ Owner | 06 May 2022, 16:18 |
| GTLB | Gitlab Inc. | 13 Oct 2021 | 0 | $0 | 3 | 10%+ Owner | 06 May 2022, 16:15 |
| VERV | Verve Therapeutics, Inc. | 21 Jun 2021 | 2 | $0 | 4 | 10%+ Owner | 22 Jun 2021, 17:20 |
| VERV | Verve Therapeutics, Inc. | 16 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 16 Jun 2021, 19:31 |